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1. Introduction 
An epileptic seizure may be conceptualized as a paroxysmal pathological process in the 
brain of a heterogeneous etiology with heteromorphic clinical and electrophysiological 
manifestation.The cases of epileptic seizures are classified according to The International 
Classification of Epileptic Seizures (ICES) published for the first time by The International 
League Against Epilepsy (ILAE) in 1970 and revised in 1981 (Commission on Classification 
and Terminology of the International League Against Epilepsy, 1981). This classification is a 
clinical one related to semiology of the seizures not to their etiology. Therefore it is 
necessary to exclude an acutely occurring cause responsible for occurrence of the seizure. In 
such cases we talk about the so-called acute symptomatic seizures. The underlying cause 
may be structural (e.g. head trauma), metabolic, toxic (e.g. alcohol), or an acute CNS 
infection, etc.. The most frequent acute symptomatic seizures are the febrile seizures. In fact, 
the acute symptomatic seizures occur more frequently than epilepsy (“unprovoked” 
seizures). The risk of occurrence during one’s life is very high - approximately 5% in males 
and 2.5% in females. If the acutely occurring cause has been withdrawn or cured without a 
residuum in the form of a brain lesion, the seizures do not recur (Dasheiff, 1987; Fromm, 
1987). The antiepileptic medication is necessary for suppressing the seizures in the acute 
stage but usually there is no need for treatment continuation after the complete cure of the 
underlying disease. If the acutely occurring cause was not responsible for epileptic seizure 
we talk about a so-called unprovoked seizure. If the unprovoked epileptic seizure occurs in 
relation to a preceding neurological insult, the disorders is regarded as secondary to this 
insult; we call it the late symptomatic epileptic seizure or late symptomatic epilepsy in case 
of seizure recurrence. A general principle of treatment for the symptomatic (secondary) 
epileptic seizures has been a primary effort for resolution of the underlying disease that is 
the etiological factor responsible for the seizures. Given that it is impossible, the 
antiepileptic treatment  in accordance with the treatment guidelines for individual seizure 
types (together with adherence to right living, behavioural precautions and concomitant 
solutions of the social and psychological issues) is indicated (Hovorka et al. 2004a; Hovorka 
et al. 2004b; Ošlejšková, 2007). Approximately 5% of the population experiences one 
unprovoked epileptic seizure in the lifetime (Forsgren et al., 1996; Hauser et al. 1993). The 
febrile seizure before the age of 5 occurs in approximately 5% of population (Hauser et al. 
1996). Only about 25% of people experiencing the first unprovoked seizure see the doctor 
and nearly always the seizure is a generalized tonic-clonic one. Most of the people have no 
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risk factors for the onset of epilepsy, normal neurological examination as well as normal 
initial EEG (Pedley et al., 1995). The occurrence of the first unprovoked epileptic seizure 
requires always a thorough evaluation. The risk of misdiagnosis is high as non-epileptic 
seizures make 20-33% of newly-diagnosed cases. 
EEG is an important non-invasive examination method that  informs about electrical activity of 
the brain. It plays an important role in differential diagnostics of seizures. The greatest 
diagnostic benefit of EEG belongs to diagnosis of epilepsy. Finding of  interictal epileptiform 
graphoelements supports the diagnosis of epilepsy with specificity of 96% (Vojtěch, 2008). In 
patients who experienced the first unprovoked epileptic seizure 30-40% catchment of specific 
epileptiform EEG abnormalities after the first EEG examination was most often reported in the 
literature (King et. al., 1998; Shinnar et al., 1994). Higher catchment was  reported in EEG 
realized within 24 hours from experienced seizure than after 24 hours (51% versus 34%) (King 
et. al., 1998). Abnormal EEG occurs more frequently in patients with partial seizures than in 
patients with generalized seizures and in patients with late symptomatic etiology of epilepsy 
than in patients with idiopathic epilepsy (Shinnar et al., 1994).  
Imaging examinations represent one of the basic methods in diagnostics of patients with 
epileptic seizures. Their development has significantly contributed to accurate diagnostics 
and classification of epileptic syndromes. It is necessary to realize that these methods can 
help reveal etiology of seizures and determine etiopathogenetic diagnosis. The fact that each 
patient after first epileptic seizure must undertake these examination is common and 
generally accepted. MRI is an advantageous imaging method for CNS. At present this 
method is the first choice method. MRI can reveal structural lesions and brain anomalies 
which CT examination, that is less sensitive, cannot (heterotopias, demyelinizations, 
anomalies of gyrifications, vascular malformations, etc.) (Bořuta et al., 2007). MRI is 
markedly more advantageous in patients with temporal epilepsy where it is able to express 
even very tiny structural changes and mesial temporal sclerosis (Carrilho et al., 1994). In 
addition, in MRI examination patients are not exposed, in contrast to CT, to radiation load. 
CT advantages involve better availability, relatively low price, possibility to examine non-
cooperating patients because the examination takes only several seconds and it is less 
sensitive to movable artifacts. Moreover, CT has less contraindications comparing to MRI. 
MRI cannot be realized in patients with metal implants and clips, pacemaker, uncontrollable 
claustrophobia. Result can be adulterated  if the patient does not cooperate. 
In the past we also evaluated the findings of various modification of EEG examination and 
imaging methods in our patients who experienced solitary unprovoked epileptic seizure 
(Kollar et. al., 2009).  We found that catchment of epileptiform manifestations in native EEG 
in patients who experienced solitary unprovoked epileptic seizure (14.29%) is lower than 
reported in literature (King et al., 1998; Shinnar et al., 1994; Vojtěch, 2008). It might be 
explained by accepted fact of transient incidence of abnormalities in EEG records. That is the 
reason that transient incidence of epileptiform EEG abnormalities in patients with epilepsy 
is considered the factor participating on different results of particular studies. High 
percentage of non-specific (non-epileptiform) abnormal EEG records in our cohort of 
patients who experienced solitary epileptic seizure was in agreement with literature data 
(Kollár et al., 2009).  The results of our study – see Table 1. 
It is very important to realize the limits of EEG examination. Firstly - normal EEG finding 
does not rule out clinical diagnosis of epilepsy and presence of epileptiform EEG 
abnormality does not confirm that the patient has epilepsy. Recurrent occurrence of 
abnormal interictal EEG findings in the group of non-epileptic seizures is also known (Kuba 
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et al., 2001). That´s why EEG must be recognized as the method that plays a very important 
role in diagnostics of epilepsy or paroxysmal disorders, however, as the adjuvant 
examination method its role is limited. In clinically clear epileptic manifestations EEG can 
confirm, or in specific cases support, clinically clear diagnosis of epilepsy. In clinically 
absent typical epileptic manifestations high cautiousness is needed in evaluation of the 
diagnosis (incorrect evaluation or over-evaluation of EEG finding). 
 
    Normal       NFA        NGA        EFA       EGA 
EEG ( n=84 )         41  
  ( 48.81 % ) 
        23 
  ( 27.38 % ) 
          8 
    ( 9.52 % )
         8 
   ( 9.52 % ) 
        4 
   ( 4.77 % ) 
EEG after SD  
    ( n1=59 ) 
        35 
  ( 59.33 % ) 
         9 
  ( 15.25 % ) 
          6 
  ( 10.17 % )
         6 
  ( 10.17 % ) 
        3 
   ( 5.08 % ) 
LTM-EEG   
  after SD 
  ( n2=46 ) 
        35 
  ( 76.09 % ) 
         6 
  ( 13.04 % )  
          2 
    ( 4.35 % )
         2 
    ( 4.35 % ) 
        1 
   ( 2.17 % ) 
Table 1. Interictal EEG findings, EEG findings after SD and LTM-EEG after SD in patients 
who experienced solitary unprovoked epileptic seizure (Kollar et al., 2009). (Abbreviations 
see in part 5). 
Statistical comparing of diagnostic benefits of CT and MRI examinations of the brain  in our 
group of patients confirmed, as in the other works, that MRI examination of the brain in 
patients who experienced solitary unprovoked epileptic seizure is definitely the first choice 
method.  The results of our  evaluation – see Table 2,3. 
 
 UNPROVOKED  SOLITARY EPILEPTIC SEIZURES 
Number of patients Number/ whole ( % ) 
CT brain       21   
Normal        5  23.81 % 
Pathology       16  76.19 % 
MRI brain        6  
Normal        2  0.33 % 
Pathology         4  0.67 % 
Realized   
CT and MRI 
      57  
CT normal 
MRI normal 
      28  49.12 % 
CT normal 
MRI pathol. 
      12  21.05 % 
CT pathol. 
MRI pathol./ 
closer specification   CT by 
MRI examination 
    17/12  29.83 % 
CT pathol. 
MRI normal 
       0      0 %    
Table 2. Findings of CT and MRI examinations of the brain in patients after solitary 
unprovoked epileptic seizure (Kollar  et al., 2009).  
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 Benefit 
CT of brain  
  ( n=57 ) 
      5 
 ( 8.77 % ) 
MRI of brain 
  ( n=57 ) 
     29 
( 50.88 % ) 
Table 3. Patients after  solitary unprovoked epileptic seizure in which both imaging methods 
were realized (Kollar et. al., 2009). 
Statistical evaluation of benefits of MRI examination comparing to CT examination by 
binomic test of proportions: p<0.0001 – high significant difference between proportions 
(Kollar et. al., 2009). 
In the past we noticed, by the EEG finding evaluation in our group of outpatients with 
epilepsy, that only in a small amount of cases the EEG findings corresponded completely 
with the clinical image of epileptic seizure (Kollar et al., 2010). In relation to the imaging 
methods and their diagnostic agreement with clinical syptomatology of epileptic seizure 
and EEG findings, it is interesting that in the study of King et al. (1998), who evaluated the 
imaging of MRI abnormalities after the first epileptic seizure in 300 members of a group, 
consisting of both children and adults, they determined that, with patients having clinically 
diagnosed partial seizure, an epileptogenic lesion on the MRI was identified in 17% of cases.  
In 50 patients with clinical diagnosis of generalized seizure a structural lesion was identified 
in only one case and in the case of 49 patients with generalized epileptiform activity on EEG 
no structural lesion on MRI was identified. These facts covey to us the need to try and 
establish in our own group of patients the clinical typology of epileptic seizure, EEG 
findings and results of imaging methods. After this we determined the part of patients with 
complete diagnostic concordance between clinical image of epileptic seizure and results of 
auxiliary diagnostic methods (Kollar et al., 2010). The summary of all watched data in the 
group of patients after solitary epileptic seizure - see Table 4. The evaluation of clinical 
typology of epileptic seizures and results or realized examination - see Table 5. 
 
The 
group  
of  
patients 
 
n 
The clinical type of 
epileptic seizure 
(ILAE,1981) 
EEG CT/MRI 
1 2 3 MT EEG 
EEG  after 
SD 
LTM-EEG 
after SD 
N P 0 
A B C A B C D E   N
N
N
A
N
F
A
E
N
A 
E
F
A
N
N
N
A
N
F
A
E
N
A
E
F
A
0 N
N
N
A
N
F
A
E
N
A
E
F
A
0
Solit.  
unprov
. EPI 
84 5 3
2
5
/ /
4
0
8 / / / 
4
1
8
2
3
4 8
3
4
6 9 3 6
2
5
3
5
2 6 1 2
3
8
45/  
30 
33/ 
33 
6/ 
21 
Table 4. The summary of all watched data in the group of patients after  solitary 
unprovoked epileptic seizure (Kollar  et al., 2010). (Abbreviations see in part 5). 
The full diagnostic coincidence between the clinical picture of epileptic seizure, EEG 
examination (native interictal EEG, or EEG after SD or LTM-EEG after SD) and results of 
imaging methods (CT or MRI of the brain) we found only in 11 from 84 patients (13,1%) 
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after solitary epileptic seizure. The receiving diagnosis of unclear seizure status was 
determined in 57 out of 116 patients (49,14%) dismissed, as mentioned in 10 years’ time 
period, with the diagnosis of solitary epileptic seizure. These percentages, together with a 
high part of unclear receiving diagnosis (the disturbance of consciousness of unclear 
etiology) in the patients, who were dismissed from our clinic with diagnosis of solitary 
epileptic seizure, suggests that the diagnosis of this group of patients is often problematic.   
 
Coincidence 
Solitary unprovoked 
EPI 
(n=84) 
Clinical typology + 
EEG (EEG after SD, 
LTM-EEG afterSD) 
16 (19,05%) 
Clinical typology  + 
CT, MRI 
52 (61,90%) 
Clinical typology + 
EEG + CT, MRI 
11 (13,10%) 
Table 5.  The evaluation of clinical symptomatology of epileptic seizures with EEG, CT and 
MRI findings (Kollar et. al., 2010).  
From unclear seizure status, which is accepted on the neurological departments, the more 
considerable part is made by unepileptic seizure status (Angus-Leppan, 2008; Perrig & 
Jallon, 2008). The correct diagnosis of seizure disorders require the strict observance of 
standard diagnostic proceeding (Martiniskova et al., 2009). The necessity are detailed 
anamnesis, adequate “erudition” of medical doctors working in this part of medicine, the 
right interpretation of auxiliary diagnostic methods results and  in many cases the quality of 
cooperation between the doctors from other specializations (Bajaček et al., 2010; Hovorka et 
al., 2007; Kollar et al., 2010). Our results repeat the confirmation that diagnostic of seizure 
disorders with or without the disturbance of consciousness belong between the more 
difficult performances in the clinical praxis. 
2. Solitary unprovoked epileptic seizure – the risk factors of probable seizure 
recurrence. To treat or not to treat the patient after the first unprovoked 
epileptic seizure? 
2.1 Introduction 
At least 5% of the general population experience one unprovoked epileptic seizure during 
their life (Forsgren et al., 1996; Hauser et al., 1982; Hauser et al., 1993). This is in contrast 
with an approximately 3-4% cumulative incidence of epilepsy (at least two unprovoked 
epileptic seizures) and with an approximately 4% incidence of the acute symptomatic 
seizures (Hauser et al., 1996). The risk of seizure recurrence after the first epileptic seizure 
has been shown to be most frequently 30-40% (range 23-71%) (Annegers et al., 1986; Engel & 
Starkman, 1994; Hauser et al., 1990; Kollar et al., 2006; Mann, 2005).  This figure oscillates 
notably depending on certain risk factors. There are multiple risk factors mentioned in the 
literature. Berg & Shinnar (1991), referring to already published studies and meta-analyses, 
stated that multiple factors influence the recurrence risk of epileptic seizures - see Table 6.  
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Etiology patients with tumours and inflammatory diseases of CNS 
have the highest risk of seizure recurrence; patients with 
focal (structural) lesions of CNS have higher risk of seizure 
recurrence than patient without focal neurological damage 
Type of seizure patients with partial seizures, particularly associated with 
Todd’s post-ictal paresis, have higher percentage of seizure 
recurrence   
EEG  appearance of the specific epileptiform abnormalities 
increases the risk 
Duration of the follow-up the risk decreases with time elapsed, the highest risk is in 
the first six months after the first seizure 
Objective neurological 
examination 
“positive finding” is an unfavourable factor (evidence of a 
structural lesion) 
Febrile convulsion history of febrile convulsions poses a higher risk of seizure 
recurrence 
Family history family history of epilepsy has been considered to be an 
unfavourable factor 
Antiepileptic treatment the lower risk of seizure recurrence with treatment 
initiation after the first seizure  
Psychosocial environment significant for the prognosis of the disease 
Table 6. Factors influencing the risk of epileptic seizure recurrence (Berg & Shinnar, 1991). 
2.2 Material and methods 
We evaluated 116 patients (68 men, 48 women; age range 18-81 years) after a solitary 
epileptic seizure that had been hospitalized at our neurological department since January 1, 
1997 to January 1, 2007. There were 84 patients having experienced an unprovoked seizure 
and 32 with an acute symptomatic epileptic seizure. The baseline information was obtained 
using a retrospective analysis of the medical records; eligible patients were contacted by 
telephone or by sending the questionnaire via the post. We evaluated the likelihood of 
seizure recurrence in 72 patients. Duration of the follow-up was 2 - 12 years. A certain 
portion of patients were followed prospectively at our outpatient department, others were 
monitored by their neurologists. We determined the number of patients in whom the 
seizure reoccurred, and time period between the first and the second epileptic seizures. We 
evaluated the following recurrence risk factors: incidence of the febrile convulsions; 
incidence of epilepsy in patients’ relatives; period of the day, when the seizure appeared; 
objective neurological examination; the clinical type of seizure; EEG findings; aetiology of 
the seizure and the influence of antiepileptic treatment initiation after the first seizure. The 
logistic regression was used for the statistical assessment of the data obtained.  
2.3 Results 
The individual risk factors and their relation to the seizure recurrence after the first 
unprovoked epileptic seizure are shown in the Table 7. 
The summary of the logistic regression: 
i. Patients with the partial epileptic seizure had 5 times higher recurrence risk (OR = 5.12, 
95 % CI: 0.79 – 32.89). 
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Patients 
with  
seizure 
recurrence  
after the first  
epileptic 
seizure
Patients  
without 
seizure 
recurrence 
Patients with 
seizure 
recurrence/ 
patients with 
seizure recurrence 
+ without  
recurrence 
Statistically 
significant 
factor in 
terms of the 
seizure 
recurrence? 
Etiology 
idiopathic + 
cryptogenic 
12 18 
      12/30 
      (40%) 
No 
late  
symptomatic 
14 28 
      14/42 
     (33.3%) 
Period of the 
day, when  
the seizure 
appears 
day-wakeful 
condition   
17 32 
      17/49   
     (34.7%) 
No 
sleep-arousal 9 14 
       9/23  
     (34.7%) 
Clinical  type of 
the 
seizure 
generalized  
 
partial  
14 
 
12 
29 
 
17 
    14/43     
   (32.5%) 
    12/29   
   (41.4%) 
No 
EEG findings 
normal + non-
epileptic 
abnormality 
20 36 
      20/56 
     (35.7%) 
No 
epileptic 
abnormality 
6 10 
       6/16  
     (37.5%) 
Objective  
neurological 
examination 
 normal  19 34 
      19/53    
     (35.8%) 
No 
pathological 7 12 
       7/19  
     (36.8%) 
History 
of the febrile 
convulsions 
Yes 0 2 
        0/2 
       (0%) 
 
No  26 34 
       26/60 
      (43.3%) 
Family history 
of epilepsy  
Yes           3         2 
        3/5  
      (60%) 
 No 
No         23        64 
       23/67   
     (34.3%) 
Antiepileptic 
treatment 
initiation after 
the first 
unprovoked  
epileptic seizure 
Yes           6        31 
         6/37   
      (16.2%) 
Yes 
No         20        15 
        20/35    
       (66.5%) 
Seizure 
recurrence after 
the first 
epileptic seizure 
within … 
3 months 
6 months 
1 year  
3 years  
5 years 
        17 
        18 
        24 
        25 
        26 
 
17/72(23.6%) 
18/72 (25%) 
24/72(33.3%) 
          25 
          26 
 
Table 7. The individual risk factors and their relation to the seizure recurrence after the first 
unprovoked epileptic seizure in our group of 72 patients. 
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ii. Patients with epileptiform EEG findings had 5 times higher recurrence risk (OR = 5.84, 
95 % CI: 0.98 -34.62). 
iii. The antiepileptic treatment initiation after the first seizure seems to be the only statistically 
significant protective factor as the patients in our group had 7 times lower recurrence risk 
compared to the patients without medication (OR= 0.13; 95% CI: 0.03 – 0,6). 
After the first unprovoked epileptic seizure we recorded the seizure recurrence in 26/72 
patients (36.1%); in 24/26 patients (92.3%) the seizure recurred within 12 months after the 
first unprovoked seizure.  
 
           
16.22%
83.78%
patients with recurrence after
first unprovoked epileptic
seizure
patients without recurrence
 
a) 
57,14%
42,86%
patients with recurrence after
first unprovoked epileptic
seizure
patients without recurrence
 
b) 
Fig. 1. Comparing  the risk for  recurrence in the group of patients , in which: 
a) an antiepileptic treatment has been prescribed after first unprovoked epileptic seizure    
(n = 37) 
b) an antiepileptic treatment  has not been prescribed after first unprovoked epileptic 
seizure (n=35) 
2.4 Discussion 
The antiepileptic treatment initiation after the first unprovoked seizure was the only 
significant factor decreasing the risk of seizure recurrence (7 times lower in our study) (OR = 
0.13, 95% CI: 0.03-0.6) in our group of 72 patients. The influence of antiepileptic treatment 
initiation on the reduction of seizure recurrence has also been reported in earlier studies 
(Elwes et al., 1985; Kollar et al., 2006). On the contrary, the significance of this factor was not 
shown in other studies (Bora et al., 1995; Hopkins et al., 1988; Musicco et al., 1997). In our 
patients there were risk factors of the seizure recurrence showing a clinical, but not 
statistical, significance – the type of epileptic seizure (5 times higher recurrence risk in 
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patients after the first partial epileptic seizure: OR = 5.12; 95%, CI: 0.79 – 32.89) and EEG 
findings (5 times higher recurrence risk in patients with epileptiform EEG findings: OR = 
5.84; 95% CI: 0.98 – 34.62). In consistence with the conclusions of Berg & Shinnar (1991) we 
observed a decrease of the recurrence risk of seizure with time that elapsed since the first 
seizure. The recurrence risk after the first unprovoked seizure was the highest within 12 
months (24/26 patients, 92.3%). The differences in results of the studies evaluating the risk 
factors of seizure recurrence after the first unprovoked epileptic seizure may be attributed to 
unequal methods and baseline criteria, as well as to diverse durations of the follow-up. The 
meta-analyses performed help us orient ourselves in this area (Berg & Shinnar, 1991). In case 
of the first unprovoked epileptic seizure appearance there is a vital need for a thorough 
evaluation (Kollar et.al., 2009; Martiniskova et al., 2009). 
3. Conclusion 
The antiepileptic treatment  initiation in patients after the solitary unprovoked epileptic 
seizure was the only statistically significant factor decreasing the risk of seizure recurrence 
in our group of patients. Based on the recent knowledge and despite of this finding we 
propose an individual, rather than automatic, antiepileptic treatment initiation, considering 
all risks, likelihood of seizure recurrence, social and psychological factors, employment and 
the potential side effects of the treatment. 
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5. Abbreviations 
Abbreviations in Table 1.  
n = whole number of patients who underwent interictal EEG examination 
n1 =  number of patients who underwent EEG after SD  
n2 = number of patients who underwent LTM-EEG after SD 
(The numbers of patients are not identical, in same cases of diagnosed epileptic disorder or 
epileptic focus the whole EEG diagnostic algorithm was not needed.) 
NFA = non-epileptiform focal EEG abnormality 
NGA = non-epileptiform generalized EEG abnormality 
EFA = epileptiform focal EEG abnormality 
EGA = epileptiform generalized EEG abnormality 
Abbreviations in Table 4.  
EEG = native EEG examination 
EEG after SD = EEG examination after sleep deprivation with one- hour recording  
LTM-EEG after SD = 24-hour eight-channel EEG examination after sleep deprivation   
n = number of patients  
NFA = non-epileptiform focal EEG abnormality  
NGA = non-epileptiform generalized EEG abnormality  
EFA = epileptiform focal EEG abnormality  
EGA = epileptiform generalized EEG abnormality  
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N - norm  
P - pathology  
0 - wasn’t realized.  
The clinical type of epileptic seizure /ILAE, 1981, being short/:  
1 - The partial (focal) seizures:  
1A - the simplex partial seizures  
1B - the complex partial seizures 
1C - the partial seizures with the secondary generalization  
2 - The generalized seizures without focal beginning (convulsive or nonconvulsive):  
2A - the absence 
2B - the myoclonic seizures  
2C - the tonic-clonic seizures  
2D - the tonic seizures  
2E – the atonic seizures  
3 - The unclassified epileptic seizures  
MT = more  types of epileptic seizures 
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